Hematology

Elotuzumab and Daratumumab Infusion for Myeloma
Elotuzumab and Daratumumab Infusion for Myeloma
BY PANELISTS: KEITH STEWART, MB CHB, KATHLEEN COLSON RN, BSN, BS, CHARISE GLEASON MSN, NP-BC, AOCNP, WENDY VOGEL, MSN, FNP, AOCNP
Explaining Antibody Therapy to Myeloma Patients
Explaining Antibody Therapy to Myeloma Patients
BY PANELISTS: KEITH STEWART, MB CHB, KATHLEEN COLSON RN, BSN, BS, CHARISE GLEASON MSN, NP-BC, AOCNP, WENDY VOGEL, MSN, FNP, AOCNP
Experience Using Monoclonal Antibodies in Myeloma
Experience Using Monoclonal Antibodies in Myeloma
BY PANELISTS: KEITH STEWART, MB CHB, KATHLEEN COLSON RN, BSN, BS, CHARISE GLEASON MSN, NP-BC, AOCNP, WENDY VOGEL, MSN, FNP, AOCNP
TKI Use in Medicare Beneficiaries With Chronic Myeloid Leukemia
TKI Use in Medicare Beneficiaries With Chronic Myeloid Leukemia
BY LISA SCHULMEISTER, RN, MN, APRN-BC, FAAN
Long-Term Response With Imatinib
Long-Term Response With Imatinib
BY LISA SCHULMEISTER, RN, MN, APRN-BC, FAAN
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.